Hipertensi Esensial

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 22

HIPERTENSI

ESENSIAL
FAKULTAS KEDOKTERAN
UNIVERSITAS MALAHAYATI
2011

DEFENISI

Hipertensi esensial adalah hipertensi


yang tidak diketahui penyebabnya.
Klasifikasi tekanan darah menurut
JNC 7 :
Klasifikasi
tekanan darah

TDS (mmHg)

TDD (mmHg)

< 120

< 80

Prahipertensi

120 139

80 89

Hipertensi derajat
1

140 159

90 99

Hipertensi derajat
2

160

100

Normal

Classification of Blood
Pressure
ESC-ESH 2007

JNC-VII

Optimal
: <120 and < 80
Normal
: 120-129 and/or 80 - 84
High Normal : 130-139 and/or 85-89
Grade 1 : 140-159 and/or 90-99
Grade 2 : 160-179 and/or 100-109
Grade 3 : > 180 and/or > 110

Normal
Pre-hypertension
Stage 1
Stage 2

H
Y
P
E
R
T
E
N
S
IO
N

JNC VII committee, JAMA 2003: 289;2560-2572

Epidemiology of
Hypertension

90% lifetime risk of developing hypertension in


people normotensive at age 55

People with lower educational and income levels


tend to higher levels of blood pressure

American Heart Association Heart Disease and Stroke statistic 2006 Update, Texas, AHA2006

Hypertension in Asia Pacific

Alexandra L.C. Martiniuk et.al J. Hypertension 2007 ; 25 : 88-92

Hypertension is Not Adequately


Treated
Off all the USA people with high blood pressure:

11% are not on treatment regimen


25% are not on adequate treatment
34% are on adequate treatment

American Heart Association Heart Disease and Stroke statistic 2006 Update, Texas, AHA2006

The Cardiovascular
Continuum
Myocardial
infarction

Coronary
thrombosis

Sudden Death
Arrhythmia &
loss of muscle

Myocardial
ischaemia
CAD
Atherosclerosis
LVH

Risk factors

Remodelling
Ventricular
dilatation
Congestive
heart failure

Death

Hypertension, smoking, cholesterol, diabetes

Dzau V. Braunwald E, Am Heart J. 1991

PATOGENESIS
Faktor yang mendorong terjadinya hipertensi :
1. Diet & asupan garam, stress, ras, obesitas,
merokok, genetis
2. Sistem saraf simpatis :
- Tonus simpatis
- Variasi diurnal
3. Keseimbangan antara modulator vasodilatasi &
vasokonstriksi
4. Pengaruh sistem endokrin setempat yang
berperan pada sistem renin, angiotensin &
aldosteron

Consequences Structural
Changes in Hypertension
Loss of buffering
Function

Increased blood pressure


Structural changes in
compliance arteries

Transmits
Systolic pressure
Wave to small arteries

Compliance

Shear stress on
Artery wall
Endothelial
dysfunction

Load on heart
Perpetuation of
Hypertension

Left Ventricular
Hypertrophy

Predisposes of
Atherosclerosis
Dzau VJ. Hypertension. 2001;37:1047-1052

The Progression from


Hypertension
to Heart Failure
LVH

Diastolic
dysfunction
CHF

Hypertension
MI

Death

Systolic
dysfunction

LV
Subclinical
Overt
Normal LV
Structure & Functionremodeling LV dysfunction Heart Failure
Time
(decades)

Time
(months)

Vasan RS, Levy D. 1996. Arch Intern Med 156 : 1759-1796

Cumulative Incidence of Heart failure in


Normotensive and Hypertensive Patients
20

Stage 2 hypertension

15
CHF
Cumulative
Incidence 10
(%)

Stage 1 hypertension

5
Normal BP

5
10
Years From Baseline Exam

15

Lenfant C, Roccella EJ. J Hypertens Suppl. 1999;17:S3-S7.


Data from Levy D et al. JAMA. 1996;275:1557-1562.

KERUSAKAN ORGAN TARGET


1.

2.
3.
4.
5.

Jantung :
- Hipertrofi ventrikel kiri
- Angina atau infark miokardium
- Gagal jantung
Otak :
- Stroke atau Transient ischemic attack
Penyakit ginjal kronis
Penyakit arteri perifer
Retinopati

Faktor resiko penyakit kardiovaskuler pada


hipertensi :
Merokok
Obesitas
Kurangnya aktivitas fisik
Dislipidemia
DM
Mikroalbuminuria
Umur ( laki-laki > 55 thn, perempuan 65
thn)
Riwayat keluarga dengan penyakit jantung
kardiovaskuler prematur (laki-laki < 55 thn,
perempuan < 65 thn)

EVALUASI HIPERTENSI
Tujuan :
1.Menilai pola hidup & identifikasi faktor-faktor
resiko kardiovaskular lainnya
2.Mencari penyebab kenaikan tekanan darah
3.Menentukan ada atau tidaknya kerusakan
target organ & penyakit kardiovaskular

Menentukan adanya penyakit


penyerta sistemik, yaitu :

Aterosklerosis

Diabetes

Penyakit ginjal

PENGOBATAN
Tujuan pengobatan :

Target tekanan darah < 140/90 mmHg

Penurunan morbiditas & mortalitas


kardiovaskular

Menghambat laju penyakit ginjal


proteinuria

Pengobatan hipertensi terdiri dari :


1. Terapi nonfarmakologis
Berhenti merokok
menurunkan berat badan
mengurangi konsumsi alkohol berlebih
latihan fisik
menurunkan asupan garam
meningkatkan konsumsi buah & sayur
menurunkan asupan lemak

2. Terapi farmakologis
Jenis-jenis obat yang dianjurkan :

Diuretika
Beta blocker
Calsium Channel Blocker atau Calcium antagonist
Angiotensin Converting Enzyme Inhibitor
Angiotensin II Receptor AT1 receptor
antagonist/blocker (ARB)
* Tunggal atau kombinasi

Possible Combinations of
Antihypertensive Agents
Diuretics

Angiotensinreceptor blockers

Beta-blockers

Diltiiazem
Alpha-blockers

Calcium
channel blockers

ACE inhibitors
Guidelines Committee. J Hypertens 2003; 21:
21: 1011-53.

LIFESTYLE MODIFICATIONS
Not Goal BP

INITIAL DRUG CHOICES

Without Compelling Indications With Compelling Indications

Stage 1

Stage 2

Thiazide-Type
diuretics for most.
May consider ACEI,
ARB, BB, CCB, or
combination

Two Drug
combination for most
(usually thiazide-type
diuretic and ACEI, or
ARB, or BB, or CCB

Drug(s) for the


compelling
indications.
Other antiHT Drugs
(Diuretics, ACEI,
ARB,

BB, CCB) as
needed

US-JNC VII Report

Renal Protection
Strict BP Control
Target BP:
<130/85 mm Hg
130/80 (ADA guidelines)
<125/75 mm Hg
(if proteinuria > 1g/24h)
Control of Proteinuria
Ideally = 0 mg/24h Mikroalbumiuri (0-300mg/24h)
American Diabetes Association. Diabetes Care. 2002;25 (Suppl.1):S85-S89.

Pemilihan obat antihipertensi dipengaruhi


oleh beberapa faktor, yaitu :
Faktor sosio ekonomi
Profil faktor resiko kardiovaskular
Ada tidaknya penyakit penyerta
Variasi individu thd obat antihipertensi
Kemungkinan adanya interaksi obat
yg digunakan pasien utk penyakit lain

You might also like